Download PDF
CC BY-NC-ND 4.0 · Indian Journal of Neurosurgery 2022; 11(03): 216-220
DOI: 10.1055/s-0040-1716936
Original Article

Serum Concentration of Myelin Basic Protein as a Prognostic Marker in Mild-to-moderate Head Injury Patients: A Prospective Study in a Tertiary Care Center

Ashvamedh Singh 
1   Department of Neurosurgery, Institute Of Medical Sciences (IMS), Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Kulwant Singh
1   Department of Neurosurgery, Institute Of Medical Sciences (IMS), Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Anurag Sahu 
1   Department of Neurosurgery, Institute Of Medical Sciences (IMS), Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
R. S. Prasad
1   Department of Neurosurgery, Institute Of Medical Sciences (IMS), Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
N. Pandey
1   Department of Neurosurgery, Institute Of Medical Sciences (IMS), Banaras Hindu University, Varanasi, Uttar Pradesh, India
,
Sambuddha Dhar
1   Department of Neurosurgery, Institute Of Medical Sciences (IMS), Banaras Hindu University, Varanasi, Uttar Pradesh, India
› Author Affiliations Funding None.
› Further Information
   Permissions and Reprints

Abstract

Objective To estimate the level of myelin basic protein (MBP) and look for its validity in outcome prediction among mild-to-moderate head injury patients.

Materials and Methods It was a prospective study done at the Department of Neurosurgery, Institute of Medical Sciences, Banaras Hindu University from Jan 2018 to July 2019. All patients who presented to us within 48 hours of injury with mild-to-moderate head injury with apparently normal CT brain were include in the study. The serum sample were collected on the day of admission and 48 hours later, and patients were treated with standard protocols and observed 6 months postdischarge.

Results Of the 32 patients enrolled, we observed mean MBP level was higher for severity of brain damage, but not associated with age, mode of injury, and radiological diagnosis. Mean MBP levels were not statistically associated with Glasgow coma scale (GCS) score at admission but was correlated to outcome with p < 0.05, with sensitivity of 50% and specificity 72%, that is, patients with good outcome have lower mean MBP levels.

Conclusion MBP as per our analysis can be used as a prognostic marker in patients with head injury. It is not the absolute value rather a trend showing rise in serum MBP levels, which carries a significant value in outcome prediction.

Keywords

MBP - serum biomarker - myelin basic protein - traumatic brain injury - serum biomarker in TBI


Publication History

Article published online:
25 May 2021

© 2021. Neurological Surgeons’ Society of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Agrawal A, Munivenkatappa A, Shukla DP. et al. Traumatic brain injury related research in India: An overview of published literature. Int J Crit Illn Inj Sci 2016; 6 (02) 65-69
    CrossrefPubMedGoogle Scholar
  • 2 Maas AI. Traumatic brain injury in India: a big problem in need of data. Neurol India 2017; 65 (02) 257-258
    CrossrefPubMedGoogle Scholar
  • 3 Bogoslovsky T, Gill J, Jeromin A, Davis C, Diaz AR. Fluid biomarkers of traumatic brain injury and intended context of use. Diagnostics (Basel) 2016; 6 (04) 37
    CrossrefPubMedGoogle Scholar
  • 4 Levin HS, Diaz-Arrastia RR. Diagnosis, prognosis, and clinical management of mild traumatic brain injury. Lancet Neurol 2015; 14 (05) 506-517
    CrossrefPubMedGoogle Scholar
  • 5 Kim HJ, Tsao JW, Stanfill AG. The current state of biomarkers of mild traumatic brain injury. JCI Insight 2018; 3 (01) e97105
    CrossrefPubMedGoogle Scholar
  • 6 Su E, Bell MJ, Kochanek PM. et al. Increased CSF concentrations of myelin basic protein after TBI in infants and children: absence of significant effect of therapeutic hypothermia. Neurocrit Care 2012; 17 (03) 401-407
    CrossrefPubMedGoogle Scholar
  • 7 Thomas DG, Palfreyman JW, Ratcliffe JG. Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury. Lancet 1978; 1 (8056) 113-115
    CrossrefPubMedGoogle Scholar
  • 8 Noseworthy TW, Anderson BJ, Noseworthy AF. et al. Cerebrospinal fluid myelin basic protein as a prognostic marker in patients with head injury. Crit Care Med 1985; 13 (09) 743-746
    CrossrefPubMedGoogle Scholar
  • 9 Gururaj G. Epidemiology of traumatic brain injuries: Indian scenario. Neurol Res 2002; 24 (01) 24-28
    CrossrefPubMedGoogle Scholar
  • 10 Nath HD, Tandon V, Mahapatra AK. et al. Outcome of head injury in unknown patients at level 1 apex trauma centre. IJNT 2011; 8 (01) 11-16
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Saxena MK, Saddichha S, Pandey V. et al. Prehospital determinants of outcome in traumatic brain injury:Experience from first comprehensive integrated prehospital care providers in India. GVK-EMRI Experience. IJNT 2010; 7 (02) 129-134
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Mao Q, Chen J, Li N. et al. [The value of serum myelin basic protein in assessment of severity of acute closed head trauma]. Hua Xi Yi Ke Da Xue Xue Bao 1995; 26 (02) 135-137
    PubMedGoogle Scholar
  • 13 Yamazaki Y, Yada K, Morii S, Kitahara T, Ohwada T. Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg Neurol 1995; 43 (03) 267-270 , discussion 270−271
    CrossrefPubMedGoogle Scholar
  • 14 Berger RP, Beers SR, Richichi R, Wiesman D, Adelson PD. Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma 2007; 24 (12) 1793-1801
    CrossrefPubMedGoogle Scholar
  • 15 Berger RP, Bazaco MC, Wagner AK, Kochanek PM, Fabio A. Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury. Dev Neurosci 2010; 32 (5-6) 396-405
    CrossrefPubMedGoogle Scholar